Digital Hive Mind’s photography will be featured in marketing efforts by NEON to support the launch of Taiho Oncology ‘s Lonsurf, which received FDA approval in September. Lonsurf is a new drug therapy for treating patients with advanced colorectal cancer who are no longer responding to other forms of treatment. Despite decreases in both the number of colorectal cancer cases and related deaths in recent years, colorectal cancer remains “the second leading cause of cancer-related death in the U.S.,” according to the FDA.
